Código QR (código de barras bidimensional)

A Nonrandomized Phase 2 Trial of EG-Mirotin, a Novel, First-in-Class, Subcutaneously Deliverable Peptide Drug for Nonproliferative Diabetic Retinopathy

<i>Background and objectives:</i> EG-Mirotin (active ingredient EGT022) targets nonproliferative diabetic retinopathy (NPDR), the early stage of retinopathy. EG-Mirotin reverses capillary damage before NPDR progresses to an irreversible stage. EG-Mirotin safety and efficacy were investigated in pati...

Fuld beskrivelse

Na minha lista:
Principais autores: Seunghoon Yoo, Dae Hyuk You, Jeongyoon Lee, H. Christian Hong, Sung Jin Lee
Format: Artigo
Sprog:Inglês
Udgivet: MDPI AG 2023-01-01
Serier:Medicina
Fag:
diabetic retinopathy
nonproliferative diabetic retinopathy
retinal ischemia
Online adgang:https://www.mdpi.com/1648-9144/59/1/178
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker